Health
newsGP – Novavax confirms efficacy against emerging coronavirus variants – RACGP
New data on Australia’s third vaccine candidate shows it is highly effective against most COVID-19 variants, which may prove crucial as production bottlenecks force…
News
New data on Australia’s third vaccine candidate shows it is highly effective against most COVID-19 variants, which may prove crucial as production bottlenecks force delays among other options.
Interim results Novavaxs phase 3 clinical trials show it has 95.6% efficacy against the main COVID strain.
The interim results from one arm of Novavax’s phase 3 clinical trials show it has 95.6% efficacy against the main coronavirus strain – and is almost as effective against the concerning UK variant,…
-
Noosa News23 hours agoTeenage boy crashes into Ipswich home, left fighting for life in hospital
-
General21 hours agoTed O’Brien was all over Chris Bowen like a wind turbine on an endangered bird
-
Business23 hours agoThe BetaShares Global Defence ETF (ARMR) is up 19% this year. Are defence stocks the new safe haven?
-
Noosa News23 hours agoEnvironment Centre NT launches legal action against government’s Mataranka water plan